Homrich & Berg’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.65M | Sell |
33,839
-868
| -3% | -$99.2K | 0.08% | 98 |
|
|
2021
Q2 | $3.91M | Buy |
34,707
+3,082
| +10% | +$347K | 0.09% | 90 |
|
|
2021
Q1 | $3.42M | Sell |
31,625
-688
| -2% | -$73.6K | 0.09% | 91 |
|
|
2020
Q4 | $3.46M | Sell |
32,313
-24
| -0.1% | -$2.31K | 0.1% | 81 |
|
|
2020
Q3 | $2.83M | Buy |
32,337
+1,730
| +6% | +$163K | 0.1% | 72 |
|
|
2020
Q2 | $3M | Buy |
30,607
+2,292
| +8% | +$202K | 0.12% | 57 |
|
|
2020
Q1 | $2.16M | Sell |
28,315
-177
| -0.6% | -$15.1K | 0.12% | 64 |
|
|
2019
Q4 | $2.52M | Buy |
28,492
+559
| +2% | +$46.4K | 0.12% | 69 |
|
|
2019
Q3 | $2.12M | Buy |
27,933
+3,829
| +16% | +$263K | 0.11% | 77 |
|
|
2019
Q2 | $1.75M | Sell |
24,104
-1,253
| -5% | -$98.5K | 0.09% | 86 |
|
|
2019
Q1 | $2.04M | Buy |
25,357
+4,724
| +23% | +$386K | 0.11% | 64 |
|
|
2018
Q4 | $1.9M | Buy |
20,633
+362
| +2% | +$31.8K | 0.11% | 69 |
|
|
2018
Q3 | $1.92M | Buy |
20,271
+716
| +4% | +$67.9K | 0.12% | 71 |
|
|
2018
Q2 | $1.81M | Buy |
19,555
+2,199
| +13% | +$215K | 0.13% | 65 |
|
|
2018
Q1 | $1.64M | Buy |
17,356
+440
| +3% | +$48.3K | 0.11% | 91 |
|
|
2017
Q4 | $1.64M | Sell |
16,916
-2,394
| -12% | -$226K | 0.11% | 90 |
|
|
2017
Q3 | $1.72M | Buy |
19,310
+1,624
| +9% | +$124K | 0.14% | 71 |
|
|
2017
Q2 | $1.28M | Buy |
17,686
+1,344
| +8% | +$90.4K | 0.11% | 82 |
|
|
2017
Q1 | $1.06M | Sell |
16,342
-81
| -0.5% | -$5.09K | 0.09% | 91 |
|
|
2016
Q4 | $1.03M | Buy |
16,423
+513
| +3% | +$31.3K | 0.09% | 81 |
|
|
2016
Q3 | $1M | Buy |
15,910
+2,460
| +18% | +$159K | 0.09% | 81 |
|
|
2016
Q2 | $833K | Buy |
13,450
+186
| +1% | +$11.3K | 0.08% | 92 |
|
|
2016
Q1 | $758K | Buy |
13,264
+920
| +7% | +$51.3K | 0.07% | 104 |
|
|
2015
Q4 | $731K | Sell |
12,344
-755
| -6% | -$43.5K | 0.07% | 114 |
|
|
2015
Q3 | $713K | Buy |
13,099
+2,541
| +24% | +$165K | 0.08% | 100 |
|
|
2015
Q2 | $709K | Buy |
10,558
+775
| +8% | +$50.6K | 0.07% | 106 |
|
|
2015
Q1 | $573K | Buy |
9,783
+1,795
| +22% | +$108K | 0.06% | 135 |
|
|
2014
Q4 | $523K | Sell |
7,988
-534
| -6% | -$33.7K | 0.05% | 143 |
|
|
2014
Q3 | $492K | Buy |
8,522
+1,342
| +19% | +$74.5K | 0.05% | 155 |
|
|
2014
Q2 | $405K | Sell |
7,180
-2,128
| -23% | -$112K | 0.05% | 149 |
|
|
2014
Q1 | $478K | Buy |
9,308
+1,303
| +16% | +$65.9K | 0.06% | 128 |
|
|
2013
Q4 | $423K | Buy |
+8,005
| New | +$393K | 0.06% | 128 |
|
|
2013
Q3 | – | Sell |
-7,862
| Closed | -$325K | – | 117 |
|
|
2013
Q2 | $325K | Buy |
+7,862
| New | +$344K | 0.06% | 115 |
|
Other funds holding ABBV
Homrich & Berg's ABBV Position: Q3 2021 in Review
Homrich & Berg reduced its AbbVie (ABBV) stake by 2.5% in Q3 2021, selling an estimated $99.2K and leaving 33,839 shares worth $3.65M. The position accounts for 0.08% of the portfolio, ranked #98.
Homrich & Berg first reported a position in ABBV in Q2 2013 and has held it in 33 quarters since. The position peaked at $3.91M in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.
- Homrich & Berg held 33,839 shares of AbbVie worth $3.65M as of Q3 2021.
- Homrich & Berg sold 868 AbbVie shares in Q3 2021, an estimated $99.2K.
- AbbVie made up 0.08% of Homrich & Berg's portfolio in Q3 2021, its #98 holding.
- Homrich & Berg first reported a position in AbbVie in Q2 2013 and has held it in 33 quarters since.
- Homrich & Berg's AbbVie position peaked at $3.91M in Q2 2021.
- 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.
Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.